Abstract:In recent years, certain amphipathic, α-helical peptides have been discovered that inhibit medically important enveloped viruses by disrupting the lipid membrane surrounding individual virus particles. Interestingly, only a small subset of amphipathic, α-helical peptides demonstrate inhibitory activity, and there is broad interest in understanding how the structures of these peptides contribute to functional activity against lipid membranes. To address this question, herein, we employed multiple surface-sensitive measurement techniques along with computational simulations in order to investigate how AH and C5A peptides, two of the most biologically active peptides in this class, interact with model lipid membranes while gaining insight into membrane-induced peptide conformational changes. Circular dichroism spectroscopy experiments revealed that both AH and C5A peptides undergo pronounced coil-to-helix transitions in the presence of lipid membrane environments, and the C5A conformational change was the largest. Time-lapsed fluorescence microscopy measurements were conducted to monitor the interaction of peptides with arrays of tethered, individual lipid vesicles and showed that C5A potently lyses lipid vesicles indiscriminate of vesicle size at peptide concentrations as low as 10 nM whereas AH peptide preferentially lyses lipid vesicles with high membrane curvature and is less potent than C5A. These findings were complemented by electrochemical impedance spectroscopy measurements on a tethered lipid bilayer membrane platform, which indicated that C5A solubilizes lipid membranes in a manner that is distinct from how AH disrupts lipid membranes via pore formation. Computational simulations supported that the distinct membrane-interaction profiles arise from different helical folding patterns, whereby AH monomers predominantly exist as two shorter helices with a hinge in-between and C5A monomers form a single helix. Taken together, our findings demonstrate that membrane-active antiviral peptides can exhibit distinct membrane-interaction profiles that confer different degrees of targeting selectivity, and the corresponding structural insights will be useful for peptide engineering applications.

Comparative Study of Interaction of Two Type Ii Ribosome-Inactivating Proteins and Their A-Chains with Model Membrane

Purification and activity study of the A- and B-chains of cinnamomin, a type II ribosome-inactivating protein.

[Study on Lysosomes Degradation of Ricin A Chain].

Identification and Biological Evaluation of a Novel Small-Molecule Inhibitor of Ricin Toxin

Structural Insights into the Interaction of the Ribosomal P Stalk Protein P2 with a Type II Ribosome-Inactivating Protein Ricin.

Baicalin Inhibits the Lethality of Ricin in Mice by Inducing Protein Oligomerization

Primary Sequence and Three-Dimensional Structural Comparison between Malanin and Ricin, a Type II Ribosome-Inactivating Protein

Proteomic Comparison of the Cytotoxicology of Two Diastereomers of Citreamicin Reveals Differentially Activation of NF-κB Pathway

Adenine Nucleotide N-Glycosidase Activity of the A-Chain of Cinnamomin Characterized by 1H-Nuclear Magnetic Resonance

Activity of Recombinant Toxin Ricin A Chain and Several Wild Type Single Chain Ribosome Inactivating Proteins

Comparative Study of Toxicity and Immunity of Recombinant Ricin A Chain and Natural Ricin

Comparing the Membrane-Interaction Profiles of Two Antiviral Peptides: Insights into Structure-Function Relationship

Studies on Crystal Structures, Active-Centre Geometry and Depurinating Mechanism of Two Ribosome-Inactivating Proteins.

Deciphering the Role of Burkholderia Cenocepacia Membrane Proteins in Antimicrobial Properties of Chitosan

Interaction of viscotoxins A3 and B with membrane model systems: implications to their mechanism of action

Comparative Analysis of Depurination Catalyzed by Ricin A-chain on Synthetic 32mer and 25mer Oligoribonucleotides Mimicking the Sarcin/ricin Domain of the Rat 28S Rrna and E. Coli 23S Rrna.

Analysis of the Interactions of Ribonuclease Inhibitor with Kanamycin

Replacement of Loop2 and 3 of Cry1Ai in Domain II Affects Specificity to the Economically Important Insect Bombyx Mori

Molecular Insight into the Inhibition Mechanism of Cyrtominetin to Α-Hemolysin by Molecular Dynamics Simulation.

Cinnamomin: separation, crystallization and preliminary X-ray diffraction study

Inhibitory Effect of Pterin Acid Against Ricin and Recombinant Ricin A Chain